2018 ASCO Annual Meeting

Gianni Bisogno, Associate Professor, University Hospital of Padova, presenting LBA2, "Maintenance low dose chemotherapy in patients with high risk (HR) rhabdomyosarcoma (RMS). A report from the European Pediatric Soft tissue sarcoma Study Group (EpSSG)," during Plenary Press Briefing

Chicago, IL - 2018 ASCO Annual Meeting - Gianni Bisogno, Associate Professor, University Hospital of Padova, presenting LBA2, "Maintenance low dose chemotherapy in patients with high risk (HR) rhabdomyosarcoma (RMS). A report from the European Pediatric Soft tissue sarcoma Study Group (EpSSG)," during Plenary Press Briefing at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Sunday June 3, 2018. Approximately 40,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 54th Annual Meeting, which is being held at McCormick Place. The ASCO Annual Meeting highlights the latest findings in all major areas of oncology, from basic to clinical and epidemiological studies. Photo by © ASCO/Zach Boyden-Holmes 2018 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org